scispace - formally typeset
Open AccessJournal ArticleDOI

Immunology of COVID-19: Current State of the Science.

Nicolas Vabret, +87 more
- 16 Jun 2020 - 
- Vol. 52, Iss: 6, pp 910-941
Reads0
Chats0
TLDR
The current state of knowledge of innate and adaptive immune responses elicited by SARS-CoV-2 infection and the immunological pathways that likely contribute to disease severity and death are summarized.
About
This article is published in Immunity.The article was published on 2020-06-16 and is currently open access. It has received 1350 citations till now.

read more

Citations
More filters
Journal ArticleDOI

Coronavirus biology and replication: implications for SARS-CoV-2.

TL;DR: The first discoveries that shape the current understanding of SARS-CoV-2 infection throughout the intracellular viral life cycle are summarized and relate that to the knowledge of coronavirus biology.
References
More filters
Posted ContentDOI

Persistent SARS-CoV-2 presence is companied with defects in adaptive immune system in non-severe COVID-19 patients

TL;DR: Persistent SARS-CoV-2 presence in non-severe COVID-19 patients is associated with reduced numbers of adaptive immune cells, and monitoring lymphocyte subpopulations could be clinically meaningful in identifying fully recovered COVID -19 patients.
Posted ContentDOI

Potent Antiviral Activities of Type I Interferons to SARS-CoV-2 Infection

TL;DR: The remarkable sensitivity of SARS-CoV-2 to recombinant human interferons α and β (IFNα/β) and the potent efficacy of human Type I IFN in suppressing Sars-Cov-2 infection is reported, which could inform future treatment options for COVID-19.
Posted ContentDOI

Analysis clinical features of COVID-19 infection in secondary epidemic area and report potential biomarkers in evaluation

TL;DR: Respiratory tract ailments and systemic symptoms were the primary symptoms of novel coronavirus infection in the secondary epidemic area; these symptoms are not typical and the abnormal increase in serum amyloid protein (SAA) may be an auxiliary index for diagnosis and treatment.
Journal ArticleDOI

Prediction and evolution of B cell epitopes of surface protein in SARS-CoV-2.

TL;DR: All 6 identified epitopes were conserved in nearly 3500 SARS-CoV-2 genomes, showing that it is helpful to obtain stable and long-acting epitopes under the condition of high frequency of amino acid mutation.
Posted ContentDOI

The IMPDH inhibitor merimepodib suppresses SARS-CoV-2 replication in vitro.

TL;DR: Evidence is provided that MMPD may be a viable treatment option for COVID-19, and concentrations as low as 3.3 μM significantly reduced viral titers when the cells were pretreated prior to infection.
Related Papers (5)